Literature DB >> 26458738

Patients with ankylosing spondylitis have been breast fed less often than healthy controls: a case-control retrospective study.

J Montoya1, N B Matta1, P Suchon2, M C Guzian1, N C Lambert3, J P Mattei1, S Guis1, M Breban4, J Roudier5, N Balandraud5.   

Abstract

OBJECTIVE: Ankylosing spondylitis (AS) is a chronic inflammatory disease affecting the spine and pelvis of young adults. On the HLA-B27 genetic background, the occurrence of AS is influenced by the intestinal microbiota. The goal of our study was to test whether breast feeding, which influences microbiota, can prevent the development of AS.
METHODS: First, 203 patients with HLA-B27-positive AS fulfilling the modified New York criteria were recruited in the Department of Rheumatology, Ste Marguerite hospital in Marseilles. A total of 293 healthy siblings were also recruited to make up a control group within the same families. Second, 280 healthy controls, and 100 patients with rheumatoid arthritis and their siblings were recruited. The data collected were age, gender, number of brothers and sisters, age at disease onset, type and duration of feeding (breast or bottle).
RESULTS: Patients with AS had been breast fed less often than healthy controls. In families where children were breast fed, the patients with AS were less often breast fed than their healthy siblings (57% vs 72%), giving an OR for AS onset of 0.53 (95% CI (0.36 to 0.77), p value=0.0009). Breast feeding reduced familial prevalence of AS. The frequency of breast feeding was similar in the AS siblings and in the 280 unrelated controls. However, patients with AS were less often breast fed compared with the 280 unrelated controls (OR 0.6, 95% CI (0.42 to 0.89), p<0.01).
CONCLUSIONS: Our study suggests a breastfeeding-induced protective effect on the occurrence of AS. To our knowledge, this is the first study of breastfeeding history in patients with AS. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

Entities:  

Keywords:  Ankylosing Spondylitis; Epidemiology; Outcomes research

Mesh:

Substances:

Year:  2015        PMID: 26458738     DOI: 10.1136/annrheumdis-2015-208187

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  16 in total

Review 1.  Relationship between diet and ankylosing spondylitis: A systematic review.

Authors:  Tatiana V Macfarlane; Hadeel M Abbood; Ejaz Pathan; Katy Gordon; Juliane Hinz; Gary J Macfarlane
Journal:  Eur J Rheumatol       Date:  2017-10-25

Review 2.  The role of gut microbiota in the pathogenesis of rheumatic diseases.

Authors:  Danli Zhong; Chanyuan Wu; Xiaofeng Zeng; Qian Wang
Journal:  Clin Rheumatol       Date:  2017-09-15       Impact factor: 2.980

Review 3.  Epidemiology of axial spondyloarthritis: an update.

Authors:  Runsheng Wang; Michael M Ward
Journal:  Curr Opin Rheumatol       Date:  2018-03       Impact factor: 5.006

Review 4.  The Microbiome: a Revolution in Treatment for Rheumatic Diseases?

Authors:  James T Rosenbaum; Mark J Asquith
Journal:  Curr Rheumatol Rep       Date:  2016-10       Impact factor: 4.592

Review 5.  How the microbiota shapes rheumatic diseases.

Authors:  Tom Van de Wiele; Jens T Van Praet; Massimo Marzorati; Michael B Drennan; Dirk Elewaut
Journal:  Nat Rev Rheumatol       Date:  2016-06-16       Impact factor: 20.543

Review 6.  The microbiota in pediatric rheumatic disease: epiphenomenon or therapeutic target?

Authors:  Matthew L Stoll; Randy Q Cron
Journal:  Curr Opin Rheumatol       Date:  2016-09       Impact factor: 5.006

Review 7.  The microbiome and HLA-B27-associated acute anterior uveitis.

Authors:  James T Rosenbaum; Mark Asquith
Journal:  Nat Rev Rheumatol       Date:  2018-12       Impact factor: 20.543

8.  Association of methylation level and transcript level in TRAF5 gene with ankylosing spondylitis: a case-control study.

Authors:  Shanshan Xu; Xing Gao; Yubo Ma; Jixiang Deng; Shengqian Xu; Faming Pan
Journal:  Genes Immun       Date:  2021-05-21       Impact factor: 2.676

9.  Ankylosing spondylitis risk factors: a systematic literature review.

Authors:  Mark C Hwang; Lauren Ridley; John D Reveille
Journal:  Clin Rheumatol       Date:  2021-03-22       Impact factor: 3.650

Review 10.  The Gut Microbiota in Immune-Mediated Inflammatory Diseases.

Authors:  Jessica D Forbes; Gary Van Domselaar; Charles N Bernstein
Journal:  Front Microbiol       Date:  2016-07-11       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.